Cannabis M&A Wave: Canopy, Vireo, and Cannabist Reshape the Industry in April 2026

The Deal Calendar Finally Starts Moving

After two years of mostly stalled deal activity and quiet balance sheets, cannabis mergers and acquisitions are accelerating again. April 2026 opened with three deal announcements that would have been notable on their own and which, taken together, tell a larger story about where the industry is going. Canopy Growth closed its acquisition of Quebec-based MTL Cannabis. Vireo Growth closed its purchase of California delivery platform Eaze. And The Cannabist Company advanced a series of court-supervised divestitures that gave the market its clearest pricing comps in years.

Cannabis M&A has never been easy, even in good years. Tax burdens under Section 280E, patchwork state regulation, and a hostile capital markets environment have all conspired to make deals slow, expensive, and heavy on earnouts. That context matters here. The April 2026 wave is not a sign that the industry has suddenly become a normal M&A market. It is a sign that the most patient and best-capitalized operators are taking advantage of a window in which distressed sellers, rescheduling anticipation, and a looser cost of capital are aligning for the first time in a while.

Canopy Growth Closes MTL Cannabis

The Canopy Growth and MTL Cannabis transaction closed with Canopy issuing 41.2 million shares plus $18.5 million in cash for the Quebec producer. The deal has two strategic dimensions worth understanding. The first is Canopy's continued reshaping of its North American footprint, with an emphasis on tightening operations and trimming exposure to categories that do not pencil out. The second is international. As part of the rationale for the transaction, Canopy highlighted the integration of California producer Lemurian, whose product is being routed into international medical supply channels.

For observers, the Canopy-MTL deal is a reminder that the Canadian licensed producer landscape is still consolidating. MTL was a well-regarded craft-oriented operator with a Quebec footprint and export capabilities, and Canopy's willingness to pay largely in shares shows how equity is, once again, becoming a usable currency. It also shows how the large Canadian LPs continue to search for operational advantages that can offset the ongoing margin pressure they face at home.

Vireo Growth Buys Eaze for $47M

Vireo Growth's $47 million acquisition of Eaze closed on April 1, 2026, putting a vertically integrated cannabis operator into direct ownership of a California and Florida delivery platform with 67 active retail locations and a lifetime count of more than 12 million deliveries. The Eaze transaction is the clearer strategic story of the week for most retail investors. Delivery has become a structural feature of the California market, and Eaze has been one of the most recognized consumer brands in that space. For Vireo, the acquisition is a way to plug in to a mature technology stack and a customer relationship layer without having to build either from scratch.

The price tag is interesting on its own. At $47 million for a platform with the scale Eaze has historically claimed, the transaction implies that the California delivery market is still priced more like a retail operator than a software operator. In a different environment, a platform with a 12-million-delivery brand equity profile might have fetched a software-style multiple. The fact that this one did not is consistent with how the broader cannabis market is still valuing ancillary technology in 2026, and it sets a benchmark that will be referenced in the next round of deals.

The Cannabist Company's Court-Supervised Wind-Down

The most important pricing signal of the month did not come from a strategic merger. It came from the court-supervised unwind of The Cannabist Company, which is producing the clearest price comparisons the cannabis industry has seen since at least 2022. Holistic Industries agreed to acquire seven Ohio subsidiaries from Cannabist for $47 million in total consideration, consisting of $34.5 million in cash at closing plus a $12.5 million promissory note. The Ohio transaction covers cultivation, production, manufacturing, distribution, and retail operations across multiple facilities and is expected to close in Q3 2026.

Separately, Cannabist sold its Delaware operations to Parma Holdco for $16.5 million cash, with that deal closing March 23, 2026. The speed of the Delaware close and the relatively clean structure of the Ohio deal are both noteworthy. Distress sales have historically been messy in cannabis because of the entangled nature of licenses, real estate leases, and regulatory approvals. The Cannabist process is showing that a court-supervised track can produce definitive values more quickly than a negotiated private sale.

For bankers, analysts, and the operating companies themselves, the practical use of these deals is not just counting dollars. It is benchmark setting. Deal comps set the expectations for the next round of negotiations, and the Cannabist comps are being circulated in deal rooms and lender offices right now.

Why This Wave Is Happening Now

Three forces are converging in April 2026 to produce a deal calendar that looked unthinkable a year ago. First, the December 2025 executive order from the Trump administration directing the attorney general to reschedule marijuana to Schedule III has shifted the regulatory probability distribution enough that buyers are no longer waiting on the sidelines. Even though the formal rescheduling process is still working through the DEA, buyers have updated their risk models.

Second, the cost of capital has loosened modestly in cannabis. It is still expensive compared to most other industries, but private credit funds that sat on the sidelines in 2024 and 2025 are reengaging, and a handful of strategic equity investors have come back into the conversation. That gives buyers more flexibility to structure deals and gives sellers more ways to exit.

Third, the distress cycle that began in late 2024 is finally producing forced sellers at volume. Operators that were hoping rescheduling would save their balance sheets before they had to choose between dilution and sale are now running out of runway. The Cannabist Company is the clearest example, but it is not the only one. Several other operators are rumored to be in similar conversations, and the lawyers who staff these processes have been busy.

What Retail Investors Should Take Away

For investors who follow cannabis equities, the April 2026 wave is worth understanding on more than a ticker level. The Canopy and Vireo closings are evidence that buyers with cash and shares are deploying them. The Cannabist wind-down is evidence that distressed sellers are finally agreeing to market-clearing prices. Both of those facts mean that the pricing floor for cannabis assets is finally being tested in real transactions rather than in thin trading on public markets.

That does not mean every operator is a buy or a target. Cannabis equities remain volatile, and deal-related bumps often reverse within a few weeks when the broader macro story takes over. But for the first time in a while, investors can point to recent, comparable transactions and talk about cannabis valuations in the same way they might talk about valuations in any other consumer-retail or CPG segment.

The Next Few Weeks to Watch

Expect more announcements. The Cannabist Company still has assets in multiple other states that are moving through the court-supervised process. Strategic buyers that have been watching the process will continue to submit and revise bids. Meanwhile, Canadian operators with U.S. ambitions and MSO operators looking to fill gaps in their geographic footprints are circling several of the remaining private operators in states like New York, Illinois, and Missouri.

The April 2026 cannabis M&A wave is not a bubble. It is a backlog clearing. Deals that should have happened in 2024 are finally happening now, and the pricing comparisons they generate are going to shape cannabis deal-making for the rest of the year.